{"id":"NCT01979133","sponsor":"University of Texas Southwestern Medical Center","briefTitle":"Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders","officialTitle":"A Proof of Concept Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2015-06","completion":"2015-06","firstPosted":"2013-11-08","resultsPosted":"2017-04-19","lastUpdate":"2017-04-19"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder","Substance Use Disorder"],"interventions":[{"type":"DRUG","name":"Icariin","otherNames":["Epimedium, Horny Goat Weed, Yin Yang Huo"]}],"arms":[{"label":"icariin","type":"EXPERIMENTAL"}],"summary":"This study is being done to see if icariin will help with depression in patients with bipolar disorder and alcohol or cocaine use disorders. The pills used in this study contain 20% icariin.","primaryOutcome":{"measure":"Change in Hamilton Rating Scale of Depression (HAMD) From Baseline to Week 8 (Exit)","timeFrame":"Baseline vs. Week 8 (Exit)","effectByArm":[{"arm":"Baseline","deltaMin":17.5,"sd":5.2},{"arm":"Week 8","deltaMin":9,"sd":7.4}],"pValues":[{"comp":"OG000 vs OG001","p":".012"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":[]}}